Education
About Us
Working with TipRanks
Follow Us
Beyond Air Inc (XAIR)
NASDAQ:XAIR
XAIR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.73 - $13.52
Previous CloseN/A
Volume845.14K
Average Volume (3M)284.19K
Market Cap
$12.99M
Enterprise Value$29.82M
Total Cash (Recent Filing)$6.92M
Total Debt (Recent Filing)$11.69M
Price to Earnings (P/E)―
Beta0.71
Next Earnings
Aug 07, 2025EPS Estimate
-1.45Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.80
Shares Outstanding4,639,739
10 Day Avg. Volume135,272
30 Day Avg. Volume284,191
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap2.30
Enterprise Value/Revenue8.05
Enterprise Value/Gross Profit-17.92
Enterprise Value/Ebitda-0.71
Forecast
1Y Price Target
$20.75Price Target Upside630.63% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Financial Performance3Q25 LungFit PH revenue of $1.1M was above estimate of $0.88M, with revenue up 34% quarter-over-quarter and 174% year-over-year.
PartnershipsBeyond Air announced an agreement with Premier, Inc., allowing Premier members to acquire LungFit PH Smart Filters with special pricing and pre-negotiated terms.
Product DevelopmentThe transport-ready LungFit PH system is expected to rapidly match and surpass the commercial adoption of GENOSYL, indicating strong market potential.
Bears Say
Commercial ChallengesBeyond Air faced setbacks and challenges in its initial commercial efforts, which limited its ability to achieve substantial revenue due to delays and disruptions during the COVID-19 pandemic and a failed agreement with a partner.
Regulatory ReviewPMA supplement to expand label to include certain cardiac surgeries is under review at the FDA.
Beyond Air News
XAIR FAQ
What was Beyond Air Inc’s price range in the past 12 months?
Beyond Air Inc lowest stock price was $2.73 and its highest was $13.52 in the past 12 months.
What is Beyond Air Inc’s market cap?
Beyond Air Inc’s market cap is $12.99M.
When is Beyond Air Inc’s upcoming earnings report date?
Beyond Air Inc’s upcoming earnings report date is Aug 07, 2025 which is 2 days ago.
How were Beyond Air Inc’s earnings last quarter?
Beyond Air Inc released its earnings results on Jun 17, 2025. The company reported -$1.8 earnings per share for the quarter, beating the consensus estimate of -$2.44 by $0.64.
Is Beyond Air Inc overvalued?
According to Wall Street analysts Beyond Air Inc’s price is currently Undervalued.
Does Beyond Air Inc pay dividends?
Beyond Air Inc does not currently pay dividends.
What is Beyond Air Inc’s EPS estimate?
Beyond Air Inc’s EPS estimate is -1.45.
How many shares outstanding does Beyond Air Inc have?
Beyond Air Inc has 4,639,739 shares outstanding.
What happened to Beyond Air Inc’s price movement after its last earnings report?
Beyond Air Inc reported an EPS of -$1.8 in its last earnings report, beating expectations of -$2.44. Following the earnings report the stock price went down -28.947%.
Which hedge fund is a major shareholder of Beyond Air Inc?
Currently, no hedge funds are holding shares in XAIR
Beyond Air Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$20.75 (630.63% Upside)
$20.75 (630.63% Upside)
Hedge Fund Trend
Decreased
By 25.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $19.4K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.1%
Last 30 Days ▲ 5.5%
Last 30 Days ▲ 5.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-65.94%
12-Months-Change
Fundamentals
Return on Equity
-241.40%
Trailing 12-Months
Asset Growth
-47.22%
Trailing 12-Months
Company Description
Beyond Air Inc
Beyond Air, Inc. (XAIR) is a medical device and biopharmaceutical company focused on developing and commercializing innovative products for patients with respiratory conditions. The company's core technology is centered around the LungFit™ platform, which is designed to deliver nitric oxide for therapeutic use in various respiratory diseases. Beyond Air operates within the healthcare sector, specifically targeting the medical devices and respiratory therapy markets.
XAIR Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presents a generally positive outlook driven by significant revenue growth, strong future guidance, and successful international expansion. However, financial challenges such as net loss and cost exceedances are areas of concern.View all XAIR earnings summariesXAIR Stock 12 Month Forecast
Average Price Target
$20.75
▲(630.63% Upside)
Technical Analysis
Ownership Overview
9.85% Insiders
2.13% Mutual Funds
0.34% Other Institutional Investors
86.13% Public Companies and
Individual Investors